| Oct 4, 2023 | Chirana T. Injecta Group's net profit fell 48.9% yoy to EUR 1.12 mil in 2022 | News | Slovakia | Pharmaceutical | Chirana T. Injecta Group | 150% |
| Oct 4, 2023 | Chirana T. Injecta Group - Profits & Sales | Chart | Slovakia | Pharmaceutical | Chirana T. Injecta Group | 150% |
| Oct 4, 2023 | Chirana T. Injecta Group's price/earnings (P/E) rose 95.6% yoy to 25.1 in 2022 | News | Slovakia | Pharmaceutical | Chirana T. Injecta Group | 125% |
| Oct 4, 2023 | Chirana T. Injecta Group's Capital Expenditures fell 153% yoy to EUR 3.80 mil in 2022 | News | Slovakia | Pharmaceutical | Chirana T. Injecta Group | 25% |
| Oct 4, 2023 | Chirana T. Injecta Group's Net Debt/EBITDA rose 415% yoy to 7.50 in 2022 | News | Slovakia | Pharmaceutical | Chirana T. Injecta Group | 13% |
| Oct 4, 2023 | Chirana T. Injecta Group's Share Price remain unchanged yoy at EUR 28.1 in 2022 | News | Slovakia | Pharmaceutical | Chirana T. Injecta Group | 13% |
| Oct 4, 2023 | Chirana T. Injecta Group's Net Margin fell 46.5% yoy to 2.23% in 2022 | News | Slovakia | Pharmaceutical | Chirana T. Injecta Group | 13% |
| Oct 4, 2023 | Chirana T. Injecta Group's ROCE fell 51.9% yoy to 2.22% in 2022 | News | Slovakia | Pharmaceutical | Chirana T. Injecta Group | 13% |
| Oct 4, 2023 | Chirana T. Injecta Group's P/FCF fell 310% yoy to -19.4 in 2022 | News | Slovakia | Pharmaceutical | Chirana T. Injecta Group | 13% |
Helgi Library 
